{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:34:00Z","timestamp":1782977640907,"version":"3.54.5"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.clim.2017.07.006","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T18:00:16Z","timestamp":1500141616000},"page":"43-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients"],"prefix":"10.1016","volume":"189","author":[{"given":"Pedro R.","family":"Lowenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clim.2017.07.006_bb0005","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1089\/hum.2005.16.741","article-title":"Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses","volume":"16","author":"Abordo-Adesida","year":"2005","journal-title":"Hum. Gene Ther."},{"issue":"6","key":"10.1016\/j.clim.2017.07.006_bb0010","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.ymthe.2004.08.025","article-title":"Inflammatory and anti-glioma effects of an adenovirus expressing human soluble Fms-like tyrosine kinase 3 ligand (hsFlt3L): treatment with hsFlt3L inhibits intracranial glioma progression","volume":"10","author":"Ali","year":"2004","journal-title":"Mol. Ther."},{"issue":"16","key":"10.1016\/j.clim.2017.07.006_bb0015","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1158\/0008-5472.CAN-04-3434","article-title":"Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model","volume":"65","author":"Ali","year":"2005","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.clim.2017.07.006_bb0020","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1158\/0008-5472.CAN-14-1203","article-title":"Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity","volume":"74","author":"Baker","year":"2014","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.clim.2017.07.006_bb0025","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S1740925X07000579","article-title":"Immunological thresholds in neurological gene therapy: highly efficient elimination of transduced cells might be related to the specific formation of immunological synapses between T cells and virus-infected brain cells","volume":"2","author":"Barcia","year":"2006","journal-title":"Neuron Glia Biol."},{"issue":"12","key":"10.1016\/j.clim.2017.07.006_bb0030","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/sj.mt.6300305","article-title":"One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implications","volume":"15","author":"Barcia","year":"2007","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/14712598.2015.972361","article-title":"Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma","volume":"15","author":"Batich","year":"2015","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.it.2006.11.007","article-title":"What is the blood-brain barrier (not)?","volume":"28","author":"Bechmann","year":"2007","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0045","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0306-4522(96)00083-8","article-title":"Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines","volume":"74","author":"Bell","year":"1996","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.clim.2017.07.006_bb0050","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1227\/NEU.0b013e3181f556ab","article-title":"Magnetic resonance imaging characteristics of glioblastoma multiforme: implications for understanding glioma ontogeny","volume":"67","author":"Bohman","year":"2010","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.clim.2017.07.006_bb0055","first-page":"166","article-title":"Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: results from a prospective population-based registry. Could survival differ in a high-volume center?","volume":"1","author":"Brandes","year":"2014","journal-title":"Neurooncol. Pract."},{"issue":"26","key":"10.1016\/j.clim.2017.07.006_bb0060","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","article-title":"Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas","volume":"372","author":"Brat","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.clim.2017.07.006_bb0065","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ctrv.2013.05.007","article-title":"Active immunotherapy using dendritic cells in the treatment of glioblastoma multiforme","volume":"39","author":"Bregy","year":"2013","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.clim.2017.07.006_bb0070","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.clim.2017.07.006_bb0075","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00401-014-1319-6","article-title":"Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications","volume":"128","author":"Buczkowicz","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.clim.2017.07.006_bb0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fonc.2015.00147","article-title":"Pathology, molecular genetics, and epigenetics of diffuse intrinsic pontine glioma","volume":"5","author":"Buczkowicz","year":"2015","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.clim.2017.07.006_bb0085","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"46","author":"Buczkowicz","year":"2014","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.clim.2017.07.006_bb0090","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1523\/JNEUROSCI.16-09-03045.1996","article-title":"Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination","volume":"16","author":"Byrnes","year":"1996","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.clim.2017.07.006_bb0095","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0306-4522(95)00068-T","article-title":"Adenovirus gene transfer causes inflammation in the brain","volume":"66","author":"Byrnes","year":"1995","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.clim.2017.07.006_bb0100","first-page":"644","article-title":"Role of T cells in inflammation caused by adenovirus vectors in the brain","volume":"3","author":"Byrnes","year":"1996","journal-title":"Gene Ther."},{"issue":"8","key":"10.1016\/j.clim.2017.07.006_bb0105","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1593\/neo.12794","article-title":"Plasmacytoid dendritic cells in the tumor microenvironment: immune targets for glioma therapeutics","volume":"14","author":"Candolfi","year":"2012","journal-title":"Neoplasia"},{"issue":"13","key":"10.1016\/j.clim.2017.07.006_bb0110","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1158\/1078-0432.CCR-09-0155","article-title":"Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity","volume":"15","author":"Candolfi","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.clim.2017.07.006_bb0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbi.2013.10.012","article-title":"Afferent and efferent immunological pathways of the brain. Anatomy, function and failure","volume":"36","author":"Carare","year":"2014","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.clim.2017.07.006_bb0120","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma","volume":"370","author":"Chinot","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ca.20887","article-title":"Cervical lymph nodes are found in direct relationship with the internal carotid artery: significance for the lymphatic drainage of the brain","volume":"23","author":"Clapham","year":"2010","journal-title":"Clin. Anat."},{"issue":"11","key":"10.1016\/j.clim.2017.07.006_bb0130","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jocn.2012.03.009","article-title":"Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: clinical, radiological and pathological studies","volume":"19","author":"Colditz","year":"2012","journal-title":"J. Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.clim.2017.07.006_bb0135","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.4049\/jimmunol.176.6.3566","article-title":"Fms-like tyrosine kinase 3 ligand recruits plasmacytoid dendritic cells to the brain","volume":"176","author":"Curtin","year":"2006","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0140","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1371\/journal.pmed.1000010","article-title":"HMGB1 mediates endogenous TLR2 activation and brain tumor regression","volume":"6","author":"Curtin","year":"2009","journal-title":"PLoS Med."},{"issue":"2","key":"10.1016\/j.clim.2017.07.006_bb0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/bjc.2015.421","article-title":"Has the survival of patients with glioblastoma changed over the years?","volume":"114","author":"deSouza","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.clim.2017.07.006_bb0150","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/15207","article-title":"Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials","volume":"5","author":"Dewey","year":"1999","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.clim.2017.07.006_bb0155","doi-asserted-by":"crossref","first-page":"10443","DOI":"10.3390\/ijms160510443","article-title":"5-ALA fluorescence image guided resection of glioblastoma multiforme: a meta-analysis of the literature","volume":"16","author":"Eljamel","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.clim.2017.07.006_bb0160","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/cncr.28935","article-title":"Bevacizumab and glioblastoma: scientific review, newly reported updates, and ongoing controversies","volume":"121","author":"Field","year":"2015","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.clim.2017.07.006_bb0165","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJMe1313309","article-title":"Bevacizumab in glioblastoma\u2014still much to learn","volume":"370","author":"Fine","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.clim.2017.07.006_bb0170","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/CCO.0000000000000135","article-title":"Perspectives for immunotherapy in glioblastoma treatment","volume":"26","author":"Finocchiaro","year":"2014","journal-title":"Curr. Opin. Oncol."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.it.2006.11.004","article-title":"What is immune privilege (not)?","volume":"28","author":"Galea","year":"2007","journal-title":"Trends Immunol."},{"issue":"40","key":"10.1016\/j.clim.2017.07.006_bb0180","doi-asserted-by":"crossref","first-page":"E4214","DOI":"10.1073\/pnas.1414389111","article-title":"Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process","volume":"111","author":"Galvao","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.clim.2017.07.006_bb0185","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1073\/pnas.1315943111","article-title":"Ischemic neurons recruit natural killer cells that accelerate brain infarction","volume":"111","author":"Gan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.clim.2017.07.006_bb0190","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1006\/mthe.2000.0140","article-title":"Strong promoters are the key to highly efficient, noninflammatory and noncytotoxic adenoviral-mediated transgene delivery into the brain in vivo","volume":"2","author":"Gerdes","year":"2000","journal-title":"Mol. Ther."},{"issue":"8","key":"10.1016\/j.clim.2017.07.006_bb0195","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A randomized trial of bevacizumab for newly diagnosed glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.clim.2017.07.006_bb0200","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMc1403303","article-title":"Bevacizumab for newly diagnosed glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.clim.2017.07.006_bb0205","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s11910-013-0346-3","article-title":"Brainstem glioma: a review","volume":"13","author":"Grimm","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"18","key":"10.1016\/j.clim.2017.07.006_bb0210","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1200\/JCO.2009.26.8789","article-title":"Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study","volume":"28","author":"Gururangan","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.clim.2017.07.006_bb0215","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1305133","article-title":"Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma","volume":"369","author":"Hamid","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2017.07.006_bb0220","first-page":"CD007415","article-title":"Temozolomide for high grade glioma","volume":"4","author":"Hart","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.clim.2017.07.006_bb0225","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1227\/NEU.0000000000001035","article-title":"Combining 5-ALA fluorescence and intraoperative MRI in glioblastoma surgery: a histology-based evaluation","volume":"78","author":"Hauser","year":"2015","journal-title":"Neurosurgery"},{"issue":"10","key":"10.1016\/j.clim.2017.07.006_bb0230","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1084\/jem.187.10.1575","article-title":"Long-term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system","volume":"187","author":"Hawke","year":"1998","journal-title":"J. Exp. Med."},{"issue":"49","key":"10.1016\/j.clim.2017.07.006_bb0235","doi-asserted-by":"crossref","first-page":"16180","DOI":"10.1523\/JNEUROSCI.3020-14.2014","article-title":"Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury","volume":"34","author":"Iliff","year":"2014","journal-title":"J. Neurosci."},{"issue":"6 Suppl 1","key":"10.1016\/j.clim.2017.07.006_bb0240","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1161\/STROKEAHA.112.678698","article-title":"Is there a cerebral lymphatic system?","volume":"44","author":"Iliff","year":"2013","journal-title":"Stroke"},{"issue":"147","key":"10.1016\/j.clim.2017.07.006_bb0245","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.clim.2017.07.006_bb0250","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1227\/NEU.0000000000001020","article-title":"The value of 5-ALA in low-grade gliomas and high-grade gliomas lacking glioblastoma imaging features: an analysis based on fluorescence, MRI, 18F-FET PET, and tumor molecular factors","volume":"78","author":"Jaber","year":"2015","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0255","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ctrv.2011.06.007","article-title":"Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology","volume":"38","author":"Jansen","year":"2012","journal-title":"Cancer Treat. Rev."},{"issue":"12","key":"10.1016\/j.clim.2017.07.006_bb0260","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","article-title":"The glymphatic system: a beginner's guide","volume":"40","author":"Jessen","year":"2015","journal-title":"Neurochem. Res."},{"issue":"309","key":"10.1016\/j.clim.2017.07.006_bb0265","doi-asserted-by":"crossref","first-page":"309ra163","DOI":"10.1126\/scitranslmed.aab0195","article-title":"Detection of human brain tumor infiltration with quantitative stimulated Raman scattering microscopy","volume":"7","author":"Ji","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"201","key":"10.1016\/j.clim.2017.07.006_bb0270","doi-asserted-by":"crossref","first-page":"201ra119","DOI":"10.1126\/scitranslmed.3005954","article-title":"Rapid, label- free detection of brain tumors with stimulated Raman scattering microscopy","volume":"5","author":"Ji","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.clim.2017.07.006_bb0275","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/hum.1997.8.3-253","article-title":"Immune responses to adenoviral vectors during gene transfer in the brain","volume":"8","author":"Kajiwara","year":"1997","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb9205","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ymthe.2016.10.003","article-title":"Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy","volume":"25","author":"Kamran","year":"2017","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.clim.2017.07.006_bb0280","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5114\/fn.2012.32361","article-title":"Established and emerging variants of glioblastoma multiforme: review of morphological and molecular features","volume":"50","author":"Karsy","year":"2012","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.clim.2017.07.006_bb0285","first-page":"CD008218","article-title":"Antiangiogenic therapy for high-grade glioma","volume":"9","author":"Khasraw","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.clim.2017.07.006_bb0290","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2990.1993.tb00476.x","article-title":"CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance","volume":"19","author":"Kida","year":"1993","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"3","key":"10.1016\/j.clim.2017.07.006_bb0295","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2990.1995.tb01048.x","article-title":"Anatomical pathways for lymphatic drainage of the brain and their pathological significance","volume":"21","author":"Kida","year":"1995","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"3","key":"10.1016\/j.clim.2017.07.006_bb0300","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1101\/gr.180612.114","article-title":"Whole- genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution","volume":"25","author":"Kim","year":"2015","journal-title":"Genome Res."},{"issue":"4","key":"10.1016\/j.clim.2017.07.006_bb0305","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/mt.2008.18","article-title":"Flt3L in combination with HSV1-TK-mediated gene therapy reverses brain tumor-induced behavioral deficits","volume":"16","author":"King","year":"2008","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0310","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1215\/15228517-2007-045","article-title":"Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model","volume":"10","author":"King","year":"2008","journal-title":"Neuro-Oncology"},{"issue":"6","key":"10.1016\/j.clim.2017.07.006_bb0315","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1227\/NEU.0b013e3181fa775b","article-title":"A systematic review of the literature on the effects of dexamethasone on the brain from in vivo human-based studies: implications for physiological brain imaging of patients with intracranial tumors","volume":"67","author":"Kotsarini","year":"2010","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.clim.2017.07.006_bb0320","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3390\/molecules14041561","article-title":"Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article","volume":"14","author":"Koukourakis","year":"2009","journal-title":"Molecules"},{"issue":"7549","key":"10.1016\/j.clim.2017.07.006_bb0325","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature14426","article-title":"Mutant MHC class II epitopes drive therapeutic immune responses to cancer","volume":"520","author":"Kreiter","year":"2015","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.clim.2017.07.006_bb0330","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ana.24271","article-title":"Impairment of paravascular clearance pathways in the aging brain","volume":"76","author":"Kress","year":"2014","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.clim.2017.07.006_bb0335","doi-asserted-by":"crossref","first-page":"e1058037","DOI":"10.1080\/2162402X.2015.1058037","article-title":"Combinatorial immunotherapy with checkpoint blockers solves the problem of metastatic melanoma-an exclamation sign with a question mark","volume":"4","author":"Kroemer","year":"2015","journal-title":"Oncoimmunology"},{"issue":"11","key":"10.1016\/j.clim.2017.07.006_bb0340","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S1470-2045(11)70130-9","article-title":"Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review","volume":"12","author":"Kubben","year":"2011","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.clim.2017.07.006_bb0345","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s11481-013-9470-8","article-title":"Drainage of cells and soluble antigen from the CNS to regional lymph nodes","volume":"8","author":"Laman","year":"2013","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0350","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"32","key":"10.1016\/j.clim.2017.07.006_bb0355","doi-asserted-by":"crossref","first-page":"14443","DOI":"10.1073\/pnas.0913496107","article-title":"Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathology","volume":"107","author":"Larocque","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2017.07.006_bb0360","first-page":"1","article-title":"A prospective phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas","author":"Lau","year":"2015","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0365","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nm.3773","article-title":"High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma","volume":"21","author":"Linnemann","year":"2015","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0370","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1471-4906(01)02063-4","article-title":"Immunology of viral-vector-mediated gene transfer into the brain: an evolutionary and developmental perspective","volume":"23","author":"Lowenstein","year":"2002","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.clim.2017.07.006_bb0375","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ymthe.2005.06.439","article-title":"The case for immunosuppression in clinical gene transfer","volume":"12","author":"Lowenstein","year":"2005","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.clim.2017.07.006_bb0380","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/156652307782151498","article-title":"Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions","volume":"7","author":"Lowenstein","year":"2007","journal-title":"Curr. Gene Ther."},{"issue":"1\u20132","key":"10.1016\/j.clim.2017.07.006_bb0385","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0165-5728(96)00082-3","article-title":"Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases","volume":"69","author":"Matyszak","year":"1996","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.clim.2017.07.006_bb0390","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0306-4522(96)00160-1","article-title":"The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system","volume":"74","author":"Matyszak","year":"1996","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0395","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-5728(97)00190-2","article-title":"Bacillus Calmette-Guerin sequestered in the brain parenchyma escapes immune recognition","volume":"82","author":"Matyszak","year":"1998","journal-title":"J. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.clim.2017.07.006_bb0400","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1474-4422(05)70118-6","article-title":"Surgery for malignant gliomas: mechanistic reasoning and slippery statistics","volume":"4","author":"Mitchell","year":"2005","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.clim.2017.07.006_bb0405","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ctrv.2013.08.008","article-title":"Immunological challenges for peptide-based immunotherapy in glioblastoma","volume":"40","author":"Mohme","year":"2014","journal-title":"Cancer Treat. Rev."},{"issue":"5","key":"10.1016\/j.clim.2017.07.006_bb0410","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/neuonc\/nov255","article-title":"Statistical considerations on prognostic models for glioma","volume":"18","author":"Molinaro","year":"2015","journal-title":"Neuro-Oncology"},{"issue":"4","key":"10.1016\/j.clim.2017.07.006_bb0415","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10014-014-0200-6","article-title":"Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review","volume":"31","author":"Nobusawa","year":"2014","journal-title":"Brain Tumor Pathol."},{"issue":"5","key":"10.1016\/j.clim.2017.07.006_bb0420","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","article-title":"Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma","volume":"17","author":"Noushmehr","year":"2010","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.clim.2017.07.006_bb0425","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11060-013-1338-5","article-title":"The role of cytotoxic chemotherapy in the management of progressive glioblastoma: a systematic review and evidence-based clinical practice guideline","volume":"118","author":"Olson","year":"2014","journal-title":"J. Neuro-Oncol."},{"issue":"17","key":"10.1016\/j.clim.2017.07.006_bb0430","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other malignant gliomas: a clinical review","volume":"310","author":"Omuro","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.clim.2017.07.006_bb0435","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-med-092012-112807","article-title":"Immune modulation in cancer with antibodies","volume":"65","author":"Page","year":"2014","journal-title":"Annu. Rev. Med."},{"issue":"7\u20138","key":"10.1016\/j.clim.2017.07.006_bb0440","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cancergen.2015.04.008","article-title":"Clinicopathology of diffuse intrinsic pontine glioma and its redefined genomic and epigenomic landscape","volume":"208","author":"Panditharatna","year":"2015","journal-title":"Cancer Genet."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-010-0360-0","article-title":"Stereotactic radiosurgery: a meta-analysis of current therapeutic applications in neuro-oncologic disease","volume":"103","author":"Pannullo","year":"2011","journal-title":"J. Neuro-Oncol."},{"issue":"3","key":"10.1016\/j.clim.2017.07.006_bb0450","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/mt.2008.284","article-title":"Striatal readministration of rAAV vectors reveals an immune response against AAV2 capsids that can be circumvented","volume":"17","author":"Peden","year":"2009","journal-title":"Mol. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2017.07.006_bb0455","first-page":"S86","article-title":"Persistent pathogens in the parenchyma of the brain","volume":"6","author":"Perry","year":"2000","journal-title":"J. Neurovirol."},{"issue":"3","key":"10.1016\/j.clim.2017.07.006_bb0460","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11060-011-0564-y","article-title":"Tissue concentration of systemically administered antineoplastic agents in human brain tumors","volume":"104","author":"Pitz","year":"2011","journal-title":"J. Neuro-Oncol."},{"issue":"2","key":"10.1016\/j.clim.2017.07.006_bb0465","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/2009.11.FOCUS09239","article-title":"The reliability of neuroanatomy as a predictor of eloquence: a review","volume":"28","author":"Pouratian","year":"2010","journal-title":"Neurosurg. Focus."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0470","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11060-015-1958-z","article-title":"A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients","volume":"126","author":"Raizer","year":"2015","journal-title":"J. Neuro-Oncol."},{"issue":"6","key":"10.1016\/j.clim.2017.07.006_bb0475","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1586\/erv.13.41","article-title":"An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma","volume":"12","author":"Reardon","year":"2013","journal-title":"Expert Rev. Vaccines"},{"issue":"3","key":"10.1016\/j.clim.2017.07.006_bb0480","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1128\/JVI.78.3.1473-1487.2004","article-title":"Systemic immune deficiency necessary for cytomegalovirus invasion of the mature brain","volume":"78","author":"Reuter","year":"2004","journal-title":"J. Virol."},{"issue":"26","key":"10.1016\/j.clim.2017.07.006_bb0485","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1017","key":"10.1016\/j.clim.2017.07.006_bb0490","doi-asserted-by":"crossref","first-page":"e729","DOI":"10.1259\/bjr\/83796755","article-title":"A clinical review of treatment outcomes in glioblastoma multiforme\u2014the validation in a non-trial population of the results of a randomised phase III clinical trial: has a more radical approach improved survival?","volume":"85","author":"Rock","year":"2012","journal-title":"Br. J. Radiol."},{"issue":"19","key":"10.1016\/j.clim.2017.07.006_bb0495","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1073\/pnas.1417320112","article-title":"Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients","volume":"112","author":"Romano","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.clim.2017.07.006_bb0500","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1227\/01.neu.0000318159.21731.cf","article-title":"Glioma extent of resection and its impact on patient outcome","volume":"62","author":"Sanai","year":"2008","journal-title":"Neurosurgery"},{"issue":"6","key":"10.1016\/j.clim.2017.07.006_bb0505","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1586\/erv.11.49","article-title":"Heat shock protein-peptide complex in the treatment of glioblastoma","volume":"10","author":"See","year":"2011","journal-title":"Expert Rev. Vaccines"},{"issue":"5","key":"10.1016\/j.clim.2017.07.006_bb0510","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrneurol.2013.56","article-title":"Progress in gene therapy for neurological disorders","volume":"9","author":"Simonato","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.clim.2017.07.006_bb0515","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","article-title":"HMGB1 and RAGE in inflammation and cancer","volume":"28","author":"Sims","year":"2010","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2017.07.006_bb0520","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1517\/14712598.2016.1141195","article-title":"Combination immune checkpoint blockade with ipilimumab and nivolumab in the management of advanced melanoma","volume":"16","author":"Spain","year":"2016","journal-title":"Expert Opin. Biol. Ther"},{"issue":"3","key":"10.1016\/j.clim.2017.07.006_bb0525","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1148\/radiol.10100343","article-title":"Fiber density mapping of gliomas: histopathologic evaluation of a diffusion-tensor imaging data processing method","volume":"257","author":"Stadlbauer","year":"2010","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.clim.2017.07.006_bb0530","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1002\/eji.1830271225","article-title":"Recruitment, activation and proliferation of CD8+ memory T cells in an immunoprivileged site","volume":"27","author":"Stevenson","year":"1997","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0535","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/viro.1997.8535","article-title":"Protection against influenza virus encephalitis by adoptive lymphocyte transfer","volume":"232","author":"Stevenson","year":"1997","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0540","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1128\/JVI.71.1.145-151.1997","article-title":"The immunogenicity of intracerebral virus infection depends on anatomical site","volume":"71","author":"Stevenson","year":"1997","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.clim.2017.07.006_bb0545","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.neuron.2008.05.031","article-title":"Glioma stem cells: a midterm exam","volume":"58","author":"Stiles","year":"2008","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.clim.2017.07.006_bb0550","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng.2925","article-title":"Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma","volume":"46","author":"Taylor","year":"2014","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0555","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/mthe.2000.0224","article-title":"Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain","volume":"3","author":"Thomas","year":"2001","journal-title":"Mol. Ther."},{"issue":"13","key":"10.1016\/j.clim.2017.07.006_bb0560","doi-asserted-by":"crossref","first-page":"7482","DOI":"10.1073\/pnas.120474397","volume":"97","author":"Thomas","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.clim.2017.07.006_bb0565","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1089\/104303401750148829","article-title":"Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectors","volume":"12","author":"Thomas","year":"2001","journal-title":"Hum. Gene Ther."},{"issue":"24","key":"10.1016\/j.clim.2017.07.006_bb0570","doi-asserted-by":"crossref","first-page":"10948","DOI":"10.1523\/JNEUROSCI.19-24-10948.1999","article-title":"Cytomegalovirus cell tropism, replication, and gene transfer in brain","volume":"19","author":"van Den Pol","year":"1999","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.clim.2017.07.006_bb0575","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/14737140.2015.974563","article-title":"A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands","volume":"15","author":"Veldhuijzen van Zanten","year":"2015","journal-title":"Expert. Rev. Anticancer. Ther."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0580","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.clim.2017.07.006_bb0585","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/07357907.2014.958234","article-title":"Dendritic cell-based vaccine for the treatment of malignant glioma: a systematic review","volume":"32","author":"Wang","year":"2014","journal-title":"Cancer Investig."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0590","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/pbc.25224","article-title":"Diffuse intrinsic pontine glioma biopsy: a single institution experience","volume":"62","author":"Wang","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"issue":"4","key":"10.1016\/j.clim.2017.07.006_bb0595","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1470-2045(15)70076-8","article-title":"Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial","volume":"16","author":"Weber","year":"2015","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.clim.2017.07.006_bb0600","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/WCO.0000000000000249","article-title":"Immunotherapy for glioblastoma: concepts and challenges","volume":"28","author":"Weiss","year":"2015","journal-title":"Curr. Opin. Neurol."},{"issue":"10","key":"10.1016\/j.clim.2017.07.006_bb0605","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00005072-199810000-00001","article-title":"Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis","volume":"57","author":"Weller","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0457-0","article-title":"Lymphatic drainage of the brain and the pathophysiology of neurological disease","volume":"117","author":"Weller","year":"2009","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.clim.2017.07.006_bb0615","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1750-3639.1996.tb00855.x","article-title":"Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways","volume":"6","author":"Weller","year":"1996","journal-title":"Brain Pathol."},{"issue":"4","key":"10.1016\/j.clim.2017.07.006_bb0620","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pathophys.2009.10.007","article-title":"Pathophysiology of the lymphatic drainage of the central nervous system: implications for pathogenesis and therapy of multiple sclerosis","volume":"17","author":"Weller","year":"2010","journal-title":"Pathophysiology"},{"issue":"4","key":"10.1016\/j.clim.2017.07.006_bb0625","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1750-3639.1992.tb00704.x","article-title":"Pathways of fluid drainage from the brain\u2014morphological aspects and immunological significance in rat and man","volume":"2","author":"Weller","year":"1992","journal-title":"Brain Pathol."},{"issue":"2","key":"10.1016\/j.clim.2017.07.006_bb0630","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","article-title":"Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease","volume":"18","author":"Weller","year":"2008","journal-title":"Brain Pathol."},{"issue":"4","key":"10.1016\/j.clim.2017.07.006_bb0635","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1517\/13543780902841951","article-title":"DCVax-brain and DC vaccines in the treatment of GBM","volume":"18","author":"Wheeler","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"2","key":"10.1016\/j.clim.2017.07.006_bb0640","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1302369","article-title":"Nivolumab plus ipilimumab in advanced melanoma","volume":"369","author":"Wolchok","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2017.07.006_bb0645","first-page":"S82","article-title":"Immunological consequences of HSV-1-mediated gene transfer into the CNS","volume":"1","author":"Wood","year":"1994","journal-title":"Gene Ther."},{"issue":"11","key":"10.1016\/j.clim.2017.07.006_bb0650","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0166-2236(96)10060-6","article-title":"Immune responses to adenovirus vectors in the nervous system","volume":"19","author":"Wood","year":"1996","journal-title":"Trends Neurosci."},{"issue":"5","key":"10.1016\/j.clim.2017.07.006_bb0655","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng.2938","article-title":"The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma","volume":"46","author":"Wu","year":"2014","journal-title":"Nat. Genet."},{"issue":"7528","key":"10.1016\/j.clim.2017.07.006_bb0660","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nature14001","article-title":"Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing","volume":"515","author":"Yadav","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.clim.2017.07.006_bb0665","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/07357907.2013.861474","article-title":"Temozolomide and radiotherapy for newly diagnosed glioblastoma multiforme: a systematic review","volume":"32","author":"Yang","year":"2014","journal-title":"Cancer Investig."},{"key":"10.1016\/j.clim.2017.07.006_bb0670","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1479-5876-11-107","article-title":"Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer","volume":"11","author":"Yang","year":"2013","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.clim.2017.07.006_bb0675","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/mt.2011.243","article-title":"Immune-mediated loss of transgene expression from virally transduced brain cells is irreversible, mediated by IFNgamma, perforin, and TNFalpha, and due to the elimination of transduced cells","volume":"20","author":"Zirger","year":"2012","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.clim.2017.07.006_bb9200","first-page":"23","article-title":"Immunology of viral-vector-mediated gene transfer into the brain: an evolutionary and developmental perspective","volume":"23","author":"Modified from Lowenstein","year":"2002"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661617305351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661617305351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T14:37:17Z","timestamp":1719326237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661617305351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":137,"alternative-id":["S1521661617305351"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2017.07.006","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2017.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}